Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Change in Receivables (2020 - 2025)

Definitive Healthcare's Change in Receivables history spans 6 years, with the latest figure at $18.0 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 2.93% year-over-year to $18.0 million; the TTM value through Dec 2025 reached -$1.4 million, up 75.69%, while the annual FY2025 figure was -$1.4 million, 75.69% up from the prior year.
  • Change in Receivables reached $18.0 million in Q4 2025 per DH's latest filing, up from -$3.5 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $25.7 million in Q4 2022 to a low of -$12.2 million in Q2 2024.
  • Average Change in Receivables over 5 years is $803000.0, with a median of -$4.9 million recorded in 2021.
  • Peak YoY movement for Change in Receivables: skyrocketed 61.43% in 2022, then tumbled 294.82% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $15.9 million in 2021, then surged by 61.43% to $25.7 million in 2022, then dropped by 27.72% to $18.6 million in 2023, then fell by 5.95% to $17.5 million in 2024, then rose by 2.93% to $18.0 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Change in Receivables are $18.0 million (Q4 2025), -$3.5 million (Q3 2025), and -$5.5 million (Q2 2025).